Testing superiority and non-inferiority hypotheses in active controlled clinical trials
- PMID: 16395997
- DOI: 10.1002/bimj.200410089
Testing superiority and non-inferiority hypotheses in active controlled clinical trials
Abstract
Switching between testing for superiority and non-inferiority has been an important statistical issue in the design and analysis of active controlled clinical trial. In practice, it is often conducted with a two-stage testing procedure. It has been assumed that there is no type I error rate adjustment required when either switching to test for non-inferiority once the data fail to support the superiority claim or switching to test for superiority once the null hypothesis of non-inferiority is rejected with a pre-specified non-inferiority margin in a generalized historical control approach. However, when using a cross-trial comparison approach for non-inferiority testing, controlling the type I error rate sometimes becomes an issue with the conventional two-stage procedure. We propose to adopt a single-stage simultaneous testing concept as proposed by Ng (2003) to test both non-inferiority and superiority hypotheses simultaneously. The proposed procedure is based on Fieller's confidence interval procedure as proposed by Hauschke et al. (1999).
Comment in
-
"Testing superiority and non-inferiority hypotheses in active controlled clinical trials".Biom J. 2006 Feb;48(1):174-5; author reply 176. doi: 10.1002/bimj.200510202. Biom J. 2006. PMID: 16544822 No abstract available.
Similar articles
-
"Testing superiority and non-inferiority hypotheses in active controlled clinical trials".Biom J. 2006 Feb;48(1):174-5; author reply 176. doi: 10.1002/bimj.200510202. Biom J. 2006. PMID: 16544822 No abstract available.
-
Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.J Biopharm Stat. 2007;17(2):247-57. doi: 10.1080/10543400601177434. J Biopharm Stat. 2007. PMID: 17365221
-
A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials.Biom J. 2005 Feb;47(1):28-36; discussion 99-107. doi: 10.1002/bimj.200410084. Biom J. 2005. PMID: 16395994 Review.
-
A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.Pharm Stat. 2007 Jul-Sep;6(3):193-203. doi: 10.1002/pst.305. Pharm Stat. 2007. PMID: 17879327
-
Clinical trials: active control vs placebo--what is ethical?Sci Eng Ethics. 2004 Jan;10(1):73-9. doi: 10.1007/s11948-004-0065-x. Sci Eng Ethics. 2004. PMID: 14986774 Review.
Cited by
-
Non-inferiority versus superiority drug claims: the (not so) subtle distinction.Trials. 2017 Jun 15;18(1):278. doi: 10.1186/s13063-017-2024-2. Trials. 2017. PMID: 28619049 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources